Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche bets on China with $468m Dx test facility in China

This article was originally published in Clinica

Executive Summary

Capitalizing on China’s increasing demand for lab testing services, Roche is planning to inject CHF450m ($468m) to build a new diagnostics plant in Suzhou Industry Park in Suzhou, Jiangsu province. The plant is Roche’s first in Asia and it will focus on producing immunochemistry and clinical chemistry tests and products that will meet the need for clinical lab testing as China continues to invest in health care.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102112

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel